4 Biotech Stocks Under $10 Moving Higher
Neuralstem
Neuralstem (CUR) is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. This stock closed up 12% to $1.28 in recent trading.
Thursday's Range: $1.22-$1.33
52-Week Range: $0.42-$1.96 Volume: 4.5 million Three-Month Average Volume: 1.2 million >>5 Stocks Insiders Love Right Now From a technical perspective, CUR is gapped up sharply higher here with above-average volume. This move followed some buying interest the prior day that came in right near its 200-day moving average of 99 cents. Shares of CUR are now pushing within range of triggering a major breakout trade. That trade will hit once CUR manages to clear some near-term overhead resistance levels at $1.38 to $1.55 with high volume. Traders should now look for long-biased trades in CUR as long as it's trending above some near-term support at $1.20, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.2 million shares. If that breakout triggers soon, then look for CUR to re-test or possibly take out its next major overhead resistance level at $1.96 to $2.03. Any high-volume move above those levels could send this stock higher towards to $2.70 to $3 in the near future.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV